Orthopedic growth slowed in Europe following an economic downturn, but it appears to finally be catching up to the U.K.-based S&N. In the third quarter, the company experienced hip and knee growth both at home and globally.
S&N is also looking to expand outside of hips and knees; its wound-care sales are forecasted to be about 30 percent of its total. Recent partnerships in Brazil and Turkey may also help propel the company in the next five years.
More Articles on Devices:
Boston Scientific’s Spinal Cord Stimulator System Results in Significant Pain Reduction, Study Finds
Blue M Medical to Launch Operations in Indiana
Osseon Therapeutics Appoints Gary Hogman Regional Sales Director
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
